Known safety concerns, contraindications, and risk factors.
Concurrent use of AMPK-activating drugs (especially metformin)
MOTS-c and its analogs primarily act by activating the AMPK pathway, creating expected interactions with other AMPK activators, most notably the common antidiabetic medication metformin.
Young, healthy individuals without metabolic dysfunction
The effects of MOTS-c appear proportional to metabolic dysfunction level. Impact and potential risk in young, healthy individuals is less understood and may offer only marginal benefits with unclear risk.
Sex-dependent dosing uncertainty
Males and females respond differently to MOTS-c, with males showing greater disruption of endogenous levels in disease states. Current research-based dosing may not be equally safe or effective for both sexes.